Sectors
TIL
Instil Bio, Inc.
7.61
2 x 5.46
2 x 9.79
bid
ask
-
0.22
2.81%
2 @ 04:10 PM
7.61 +0.00 (0.00%)
| Ytd | -30.82% | |
| 1y | -71.81% |
7.54
day range
7.69
5.67
52 week range
33.83
| Open | 7.69 | Prev Close | 7.83 | Low | 7.54 | High | 7.69 | Mkt Cap | 51.61M |
| Vol | 2.60K | Avg Vol | 12.56K | EPS | -4.25 | P/E | N/A | Forward P/E | -1.80 |
| Beta | 1.74 | Short Ratio | 2.29 | Inst. Own | 80.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-04 | 50-d Avg | 7.47 | 200-d Avg | 8.62 | 1yr Est | 100.33 |
| Income Statement | |||
| Operating Expenses | 5.58M | ||
| Research and Development Expense | 270.00K | ||
| Selling, General and Administrative Expense | 5.13M | ||
| Operating Income | -5.58M | ||
| Interest Expense | 1.58M | ||
| Net Income | -4.30M | ||
| Net Income Common Stock | -4.30M | ||
| Net Income Common Stock (USD) | -4.30M | ||
| Consolidated Income | -4.30M | ||
| Earnings per Basic Share | -0.63 | ||
| Earnings per Basic Share (USD) | -0.63 | ||
| Earnings per Diluted Share | -0.63 | ||
| Earning Before Interest & Taxes (EBIT) | -2.72M | ||
| Earning Before Interest & Taxes (USD) | -2.72M | ||
| Weighted Average Shares | 6.78M | ||
| Weighted Average Shares Diluted | 6.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.80M | ||
| Cash and Equivalents (USD) | 5.80M | ||
| Investments | 64.14M | ||
| Investments Current | 64.14M | ||
| Current Assets | 71.61M | ||
| Property, Plant & Equipment Net | 113.93M | ||
| Total Assets | 197.71M | ||
| Total Debt | 87.03M | ||
| Current Liabilities | 3.31M | ||
| Debt Non-Current | 87.03M | ||
| Total Liabilities | 90.33M | ||
| Accumulated Retained Earnings (Deficit) | -734.99M | ||
| Accumulated Other Comprehensive Income | -587.00K | ||
| Shareholders Equity | 107.38M | ||
| Shareholders Equity (USD) | 107.38M | ||
| Assets Non-Current | 126.11M | ||
| Total Debt (USD) | 87.03M | ||
| Liabilities Non-Current | 87.03M | ||
| Trade and Non-Trade Payables | 795.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 274.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 649.00K | ||
| Net Cash Flow from Investing | 5.29M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.29M | ||
| Net Cash Flow from Operations | -4.64M | ||
| Effect of Exchange Rate Changes on Cash | 1000 | ||
| Share Based Compensation | 1.04M | ||